Oral iron in HFrEF with iron deficiency: an overlooked treatment strategy?

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Mr Antonio Angelico-Goncalves

Unidade local de Saude Gaia/Espinho EPE, Vila Nova de Gaia (Portugal)

6 More presentations in this session

Presentation thumbnail

Stimulation in home based cardiac rehabilitation protocol, the effect on aerobic capacity and quality of life

Assistant Professor R. Kallel (Gabes, TN)

Abstract Slides

Presentation thumbnail

The impact of midodrine on patients with heart failure with reduced ejection fraction- retrospective cohort study

Doctor J. Mahar (Phoenix, US)

Abstract Slides

Presentation thumbnail

Survival impact of amiodarone therapy in heart failure: insights from the Icelandic Heart Failure registry

Doctor P. Gudjonsson (Reykjavik, IS)

Abstract Slides

Presentation thumbnail

Efficacy and safety of GLP-1 agonists in obesity-related heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomized placebo-controlled trials.

Miss J. Khater (Beirut, LB)

Abstract Slides

Presentation thumbnail

Efficacy of intravenous and oral iron replacement therapies in heart failure: a network meta-analysis

Mr R. Mizori (London, GB)

Abstract Slides

Access the full session

Session thumbnail

Managing comorbidities in heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Therapeutic implications of the cardio-renal-metabolic multimorbidity

Congress Presentation

Obesity and inactivity cluster is the strongest predictor of incident heart failure in a population-based study

Congress Presentation

Defining patterns of comorbidity accrual before and after the diagnosis of heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources